Back to AI Alyeska Investment Group, L.P.

EPRXEPRX
4 quarters

Position history for AIAlyeska Investment Group, L.P.'s holdings in EUPRAXIA PHARMACEUTICALS INC

Alyeska Investment Group, L.P. holds 375,000 shares of EPRX (EUPRAXIA PHARMACEUTICALS INC), worth $2.5M as of 2026-Q2. EPRX represents 0.0% of Alyeska Investment Group, L.P.'s portfolio.

Current Value

$2.5M

Current Shares

375,000

Total Value Change

+$1M

Total Shares Change

+125,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
375,000
0.0%
$2.5M0.0%$6.61
0
2026-Q1
New
375,000
-
$2.7M0.0%$8.02
36
2025-Q4
Exited
0
-100.0%
$00.0%$7.59
0
2025-Q3
New
250,000
-
$1.5M0.0%$5.75
35

Other major holders of EPRX: BALYASNY ASSET MANAGEMENT L.P., SCOTIA CAPITAL INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used